In-111 Capromab Pendetide (ProstaScint)
This radiotracer, which binds preferentially to prostate membrane specific antigen (PMSA), is used to localize protate adenocarcinoma.
Go back to Oncology (Nuclear) imaging.
Go back to Oncology (Nuclear) imaging.
Normal biodistribution
Coming soon
Resources
Wong TZ et al. "ProstaScint (Capromab Pendetide) Imaging Using Hybrid Gamma Camera–CT Technology." AJR 2005; 184(2):676-680.
Gordon L. "Prostate Imaging" Presentation on ProstaScint. 2008.
Gordon L. "Prostate Imaging" Presentation on ProstaScint. 2008.